COL14A1 is altered in 0.06% of all cancers with breast invasive ductal carcinoma, cholangiocarcinoma, adenocarcinoma of unknown primary, adenocarcinoma of the gastroesophageal junction, and esophageal adenocarcinoma having the greatest prevalence of alterations .
The most common alterations in COL14A1 are COL14A1-DEPDC6 Fusion (0.01%), COL14A1-IGF1R Fusion (0.01%), and COL14A1-SMARCA4 Fusion (0.00%) .
2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.
3. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.